Methotrexate: An option for preventing the recurrence of acute anterior uveitis

Eye

Volumn 23, Issue 5, 2009, Pages 1130-1133

  Muoz Fernandez S ^a   Garcia Aparicio A M ^b   Hidalgo, M V ^c   Platero, M ^b   Schlincker, A ^c   Bascones, M L ^b   Pombo, M ^c   Morente, P ^b   Sanpedro, J ^b   Martin Mola E ^c  

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Anterior uveitis; Methotrexate; Treatment; Uveitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; CYCLOPLEGIC AGENT; FOLIC ACID; METHOTREXATE; MYDRIATIC AGENT;

ACUTE DISEASE; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; IRIDOCYCLITIS; LOADING DRUG DOSE; LONGITUDINAL STUDY; MALE; OPHTHALMOLOGY; RECURRENT DISEASE; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; UVEITIS, ANTERIOR; YOUNG ADULT;

EID: 65949120415     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.198     Document Type: Article

References (19)

1. Bañares A, Jover JA, Fernández-Gutierrez B, Benitez JM, García J, Vargas E et al. Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses. Arthritis Rheum 1997; 40: 358-370.
2. Bañares A, Hernández-García C, Fernández- Gutierrez B, Jover JA. Eye involvement in the spondyloarthropathies. Rheum Dis Clin N Am 1998; 24: 771-784.
3. Smith JR, Rosenbaum JT. Management of uveitis. A rheumatologic perspective. Arthritis Rheum 2002; 46: 309-318.
4. Muñoz Fernández S, Martín-Mola E. Uveitis. Best Pract Res Clin Rheumatol 2006; 20(3): 487-505.
5. Dougados M, Berenbaum F, Maetzel A, Amor B. Prévention des épides d́uvéite antérieurë aigue des spondylarthropathies par la salazosulfapyridine. Rev Rhum 1993; 60: 81-83.
6. Benitez-del-Castillo JM, García-Sánchez J, Iradier T, Bañares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 2000; 14: 340-343.
7. Muñoz-Fernández S, Hidalgo V, Fernández-Melón J, Schlicker A, Bonilla G, ruiz-Sancho D et al. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol 2003; 30: 1277-1279.
8. Samson CM, Waheed N, Baltatzis S, Foster CS. Metothotrexate therapy for chronic noninfectious uveitis: an anlysis of a case series of 160 patients. Ophthalmology 2001; 108: 1134-1139.
9. Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005; 32: 362-365.
10. Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol 2005; 89: 806-808.
11. Weinblatt ME, Maier AL. Longterm experience with low dose weekly methotrexate in rheumatoid arthritis. J Rheumatol(Suppl.) 1990; 22: 33-38.
12. Genovese MC, Harris ED. Treatment of rheumatoid arthritis. In: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S and Sledge CB (eds). Kelley's textbook of Rheumatology, 7th ed. Elservier: Saunders, 2005; pp 1079-1100.
13. Amos RS, Pullar T, Bax DE, Situnayake D, Capell HA, McConkey B. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J 1986; 293: 420-423.
14. Rau R, Schleusser B, Herborn G, Karger T. Long-term treatment of destructive rheumatoid arthritis with methotrexate. J Rheumatol 1997; 24: 1881-1889.
15. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987; 103: 234-235.
16. Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Ophthalmol 2003; 110: 1764-1769.
17. Braun J, Baraliakos X, Listing J, Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 2005; 52: 2447-2451.
18. Rosenbaum JT. Effect of etanercept on iritis in patients with ankylosing spondylitis. Arthritis Rheum 2004; 50: 3736-3737.
19. Guignard S, Gossec L, Salliot C, Ruyssen-Witrand A, Luc M, Duclos M et al. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis 2006; 65: 1631-1634.